74 results on '"DALL'OLIO, FABIO"'
Search Results
2. Immunoglobulin G Glycosylation Changes in Aging and Other Inflammatory Conditions
3. Convenient and Sensitive Measurement of Lactosylceramide Synthase Activity Using Deuterated Glucosylceramide and Mass Spectrometry
4. Glycobiology of Aging
5. N-Glycan on the Non-Consensus N-X-C Glycosylation Site Impacts Activity, Stability, and Localization of the Sda Synthase B4GALNT2
6. The Mutual Relationship between Glycosylation and Non-Coding RNAs in Cancer and Other Physio-Pathological Conditions
7. The story of the Sda antigen and of its cognate enzyme B4GALNT2: What is new?
8. Glycosyltransferases in Cancer: Prognostic Biomarkers of Survival in Patient Cohorts and Impact on Malignancy in Experimental Models
9. The Cancer-Associated Antigens Sialyl Lewisa/x and Sda: Two Opposite Faces of Terminal Glycosylation
10. Glycobiology of the Epithelial to Mesenchymal Transition
11. Glycosyltransferase B4GALNT2 as a Predictor of Good Prognosis in Colon Cancer: Lessons from Databases
12. Bladder cancer–glycosylation insights
13. L1CAM as an E-selectin Ligand in Colon Cancer
14. The Sda Synthase B4GALNT2 Reduces Malignancy and Stemness in Colon Cancer Cell Lines Independently of Sialyl Lewis X Inhibition
15. High Expression of the Sda Synthase B4GALNT2 Associates with Good Prognosis and Attenuates Stemness in Colon Cancer
16. A novel nonsense and inactivating variant of ST3GAL3 in two infant siblings suffering severe epilepsy and expressing circulating CA19.9
17. Carcinoembryonic antigen is a sialyl Lewis x/a carrier and an E‑selectin ligand in non‑small cell lung cancer
18. Impact of sialyltransferase ST6GAL1 overexpression on different colon cancer cell types
19. Total loss of GM3 synthase activity by a normally processed enzyme in a novel variant and in all ST3GAL5 variants reported to cause a distinct congenital disorder of glycosylation
20. The extended cytoplasmic tail of the human B4GALNT2 is critical for its Golgi targeting and post‐Golgi sorting
21. Diseases of ganglioside biosynthesis: An expanding group of congenital disorders of glycosylation
22. Oxidative damage and response to Bacillus Calmette-Guérin in bladder cancer cells expressing sialyltransferase ST3GAL1
23. Glycosylation as a Main Regulator of Growth and Death Factor Receptors Signaling
24. Epigenetic Bases of Aberrant Glycosylation in Cancer
25. Expression of sialyl-Tn sugar antigen in bladder cancer cells affects response to Bacillus Calmette Guérin (BCG) and to oxidative damage
26. Selectin Ligands Sialyl-Lewis a and Sialyl-Lewis x in Gastrointestinal Cancers
27. Identification of novel plasma glycosylation-associated markers of aging
28. β-Galactoside α2,6-Sialyltransferase and the Sialyl α2,6-Galactosyl-Linkage in Tissues and Cell Lines
29. Sialosignaling: Sialyltransferases as engines of self-fueling loops in cancer progression
30. Control of Glycosylation-Related Genes by DNA Methylation: the Intriguing Case of the B3GALT5 Gene and Its Distinct Promoters
31. B4GALNT2 gene expression controls the biosynthesis of Sda and sialyl Lewis X antigens in healthy and cancer human gastrointestinal tract
32. Sialyl Tn-expressing bladder cancer cells induce a tolerogenic phenotype in innate and adaptive immune cells
33. The expanding roles of the Sda/Cad carbohydrate antigen and its cognate glycosyltransferase B4GALNT2
34. Transcriptional control of theB3GALT5gene by a retroviral promoter and methylation of distant regulatory elements
35. Overexpression of tumour-ssociated carbohydrate antigen sialyl-Tn in advanced bladder tumours
36. N-glycomic biomarkers of biological aging and longevity: A link with inflammaging
37. Apoptotic cells selectively uptake minor glycoforms of vitronectin from serum
38. DNA methylation and histone modifications modulate the β1,3 galactosyltransferase β3Gal-T5 native promoter in cancer cells
39. Mechanisms of cancer-associated glycosylation changes
40. Corrigendum to “The biosynthesis of the selectin-ligand sialyl Lewis x in colorectal cancer tissues is regulated by fucosyltransferase VI and can be inhibited by an RNA interference-based approach” [Int. J. Biochem. Cell Biol. 43 (1) (2011) 130–139]
41. The biosynthesis of the selectin-ligand sialyl Lewis x in colorectal cancer tissues is regulated by fucosyltransferase VI and can be inhibited by an RNA interference-based approach
42. Contribution of Thomsen-Friedenreich antigens to bladder cancer malignancy: Characterization of cell line models
43. ST3Gal.I sialyltransferase relevance in bladder cancer tissues and cell lines
44. Surface α2-3- and α2-6-sialylation of human monocytes and derived dendritic cells and its influence on endocytosis
45. Biosynthesis and expression of the Sda and sialyl Lewis x antigens in normal and cancer colon
46. Role ofBifidobacterium longum in the induction of apoptotic deletion in the human enterocyte-like Caco-2 cell line
47. Phenotypic changes induced by expression of β-galactoside α2,6 sialyltransferase I in the human colon cancer cell line SW948
48. Ras oncogene induces β-galactoside α2,6-sialyltransferase (ST6Gal I) via a RalGEF-mediated signal to its housekeeping promoter
49. Evaluation of Thymidylate Synthase Protein Expression by Western Blotting and Immunohistochemistry on Human Colon Carcinoma Xenografts in Nude Mice
50. Biosynthesis of the cancer-related sialyl-α2,6-lactosaminyl epitope in colon cancer cell lines expressing β-galactoside α2,6-sialyltransferase under a constitutive promoter
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.